ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,069,000 | -24.2% | 249,215 | -46.4% | 0.05% | -31.1% |
| Q2 2021 | $1,410,000 | -17.4% | 465,317 | -16.4% | 0.07% | -36.2% |
| Q1 2021 | $1,707,000 | +3.3% | 556,617 | +19.6% | 0.12% | -21.6% |
| Q4 2020 | $1,652,000 | +6.9% | 465,317 | -11.0% | 0.15% | -41.0% |
| Q3 2020 | $1,545,000 | -80.4% | 522,649 | -87.9% | 0.25% | -80.8% |
| Q2 2020 | $7,882,000 | +80.2% | 4,331,020 | 0.0% | 1.31% | +30.5% |
| Q1 2020 | $4,374,000 | +69.9% | 4,331,020 | +367.6% | 1.00% | +348.2% |
| Q4 2019 | $2,575,000 | – | 926,200 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |